Novartis top lawyer exits in wake of Trump attorney deal
ZURICH (Reuters) – Novartis (NOVN.S) General Counsel Felix Ehrat will leave the Swiss drugmaker over his role in a $1.2 million contract it struck with the personal lawyer for U.S.…
Novartis ditches lawyer as head rolls over Trump lawyer deal
ZURICH (Reuters) – Novartis (NOVN.S) General Counsel Felix Ehrat will leave the Swiss drugmaker over his role in a $1.2 million contract it struck with the lawyer for U.S. President…
J&J defends itself in trial over baby powder asbestos claims
(Reuters) – A trial for a lawsuit alleging that Johnson & Johnson Baby Powder was responsible for the death of a woman due to her exposure to cancer-causing asbestos began…
WHO hopes to use Ebola vaccine to stem outbreak in remote area of Congo
GENEVA (Reuters) – The World Health Organization said on Friday it hopes to deploy an experimental Ebola vaccine to tackle an outbreak in a remote area of Congo to prevent…
Health charity Wellcome pledges funds, calls for rapid response to Ebola in Congo
(Reuters) – Britain’s Wellcome Trust global health charity called for a rapid response to an outbreak of Ebola in the Democratic Republic of Congo (DRC) and has pledged 2 million…
Jazz Pharmaceuticals to settle U.S. probe for $57 million
BOSTON (Reuters) – Jazz Pharmaceuticals Plc said on Tuesday it had agreed to pay $57 million to resolve a U.S. probe into its financial support of charities that offer assistance…
FDA says Mylan’s EpiPen is in shortage
(Reuters) – U.S. regulators said on Wednesday that Mylan NV’s (MYL.O) EpiPen products are in shortage, due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy…
U.S. drug agency suspends Louisiana distributor over opioid sales
WASHINGTON (Reuters) – The U.S. Drug Enforcement Administration said on Friday it had suspended a Louisiana pharmaceutical distributor from selling controlled substances for allegedly selling unusually large quantities of opioids…
FDA chief questions protections on drug rebates, stocks fall
(Reuters) – U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health insurers should remain protected by federal law, sparking new concerns…
Scientists devise new, more accurate peanut allergy test
LONDON (Reuters) – British scientists have developed a far more accurate blood test to diagnose peanut allergy, offering a better way to monitor a significant food hazard. Peanuts are the…